SCHEMBL6417680

SCHEMBL6417680

Cc1n[nH]c(C)c1S(=O)(=O)c1ccc([N+](=O)[O-])cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.54
▸ KDM4E B2RXH2 1/20 0.54
▸ TDP1 Q9NUW8 1/20 0.54
▸ KMT2A Q03164 3/20 0.47
▸ MEN1 O00255 1/20 0.47
▸ HSP90AA1 P07900 1/20 0.44
▸ CXCR5 P32302 1/20 0.44
▸ APLNR P35414 1/20 0.44
▸ RAB9A P51151 1/20 0.44
▸ CCR6 P51684 1/20 0.44
▸ GFER P55789 1/20 0.44
▸ HTT P42858 1/20 0.43
▸ CA12 O43570 3/20 0.42
▸ CA1 P00915 3/20 0.42
▸ CA2 P00918 3/20 0.42
▸ CA3 P07451 3/20 0.42
▸ CA4 P22748 3/20 0.42
▸ CA6 P23280 3/20 0.42
▸ CA5A P35218 3/20 0.42
▸ CA7 P43166 3/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22494202 0.74 CYP2C9 (0.50) ALDH1A1KDM4ETDP1KMT2AMEN1
SCHEMBL7529478 0.73 KDM4E (0.57) ALDH1A1KDM4ETDP1KMT2AMEN1
SCHEMBL11419996 0.72 CA2 (0.67) ALDH1A1KMT2AHTTCA12CA1
SCHEMBL11855965 0.72 CA2 (0.67) ALDH1A1KMT2AHTTCA12CA1
SCHEMBL3158508 0.72 CA2 (0.67) ALDH1A1KMT2AHTTCA12CA1
SCHEMBL6417531 0.72 AR (0.39) ALDH1A1KDM4ETDP1KMT2AMEN1
SCHEMBL6577803 0.71 ACHE (0.75) ALDH1A1KMT2AMEN1HSP90AA1CXCR5
SCHEMBL28629280 0.70 ALDH1A1 (0.54) ALDH1A1KDM4ETDP1KMT2AMEN1
SCHEMBL27920917 0.70 MEN1 (0.60) ALDH1A1KDM4ETDP1KMT2AMEN1
SCHEMBL6416951 0.70 ALDH1A1 (1.00) ALDH1A1KDM4ETDP1KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050119489-A1 4-Sulfide/sulfoxide/sulfonyl-1h-pyrazolyl derivative compounds, for use in diseases associated with the 5-ht2c receptor BAYER HEALTHCARE AG (DE) 2005-06-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050119489-A1 4-Sulfide/sulfoxide/sulfonyl-1h-pyrazolyl derivative compounds, for use in diseases associated with the 5-ht2c receptor HTR2C, HTR2A, HTR2B ALDH1A1 813/4885KDM4E 2840/4885TDP1 4000/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback